Lexeo Therapeutics, Inc

The annual 10-K, the quarterly 10-Q and the 8-K filed between them when something material happens.

1. Sep 298-KAcquisition or sale of assets completed and unregistered sale of shares2.013.029.01
2. Sep 228-KMaterial agreement and other events1.018.019.01
3. Aug 1413GPassive stake of 5% or more (13G), filed by Orbimed Advisors
4. Aug 1210-QQuarterly report
5. Aug 128-KResults of operations and other events2.028.019.01
6. Aug 713GPassive stake of 5% or more (13G)
7. Jun 298-KShareholder vote5.07
8. Jun 158-KRegulation FD disclosure and other events7.018.019.01
9. May 1110-QQuarterly report
10. May 118-KResults of operations and other events2.028.019.01
11. Apr 308-KOfficer or director change5.02
12. Mar 3010-KAnnual report
13. Mar 308-KResults of operations and other events2.028.019.01
14. Feb 58-KOfficer or director change5.02
15. Jan 278-KOfficer or director change5.02
16. Jan 128-KRegulation FD disclosure and other events7.018.019.01
17. Nov 26, 2025424B3Prospectus for an offering
18. Nov 5, 2025S-3Shelf registration
19. Nov 5, 202510-QQuarterly report
20. Nov 5, 20258-KResults of operations2.029.01
21. Oct 17, 20258-KMaterial agreement and results of operations1.012.023.028.019.01
22. Oct 17, 2025424B5Prospectus for an offering
23. Oct 16, 2025424B5Prospectus for an offering
24. Oct 7, 20258-KRegulation FD disclosure and other events7.018.019.01
25. Aug 14, 202510-QQuarterly report
26. Aug 14, 20258-KResults of operations and officer or director change2.025.029.01
27. Jul 1, 2025424B3Prospectus for an offering
28. Jun 30, 20258-KShareholder vote5.07
29. Jun 13, 2025S-3Shelf registration
30. May 27, 20258-KMaterial agreement and unregistered sale of shares1.013.027.019.01
31. May 12, 202510-QQuarterly report
32. May 12, 20258-KResults of operations2.029.01